Leah D'Aurora Richardson

Aug 22, 2023 | jdsupra.com | Darlene Davis |Leah D'Aurora Richardson |Andrew Ruskin

In this episode, Darlene Davis, Leah Richardson, and Andrew Ruskin unravel CMS’s proposed rule for the remedy for Medicare payments for drugs purchased under the 340B Program and reimbursed as hospital outpatient services. The discussion includes background of the unlawful 340B drug reimbursement policy, as well as CMS’s proposed remedy.

May 10, 2023 | klgates.com | Gina Bertolini |Leah D'Aurora Richardson |Stephen Page |Hannah Maroney

11 May 2023US Health Care and FDA Alert Executive Summary The Drug Enforcement Administration (DEA) issued a temporary rule (Temporary Rule), effective 11 May 2023, extending flexibilities regarding the prescribing of controlled substances via telemedicine that have been in place since the beginning of the COVID-19 public health emergency (PHE). These flexibilities will remain in place through 11 November 2023.

Feb 7, 2023 | jdsupra.com | Gina Bertolini |Stephen Page |Leah D'Aurora Richardson

On 29 December 2022, President Biden signed into law the Consolidated Appropriations Act of 2023 (the Act),1 allocating US$1.7 trillion in government spending. The Act contains hundreds of pages of legislation on a myriad of topics, including extensions of telehealth flexibilities beyond the COVID-19 public health emergency (PHE).